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A B S T R A C T   
Olive pomace is a biowaste rich in polyphenols and insoluble dietary fibre with high potential to develop new 
value chains towards a sustainable and circular bioeconomy. Regarding gut health, olive pomace phenolics and 
insoluble dietary fibre (after possible fermentation) could act as antioxidants, antimicrobial and prebiotic agents. 
These potential beneficial effects on the gut were analysed for two powders from olive pomace: liquid-enriched 
powder (LOPP) - mostly source of phenolics - and pulp-enriched powder (POPP) - main source of insoluble di-
etary fibre. LOPP and POPP were subjected to an in vitro simulated gastrointestinal digestion followed by in vitro 
faecal fermentation. The undigested fraction retained in the colon was analysed regarding its potential antiox-
idant, antimicrobial and prebiotic effects. LOPP and POPP did not impact the gut microbiota diversity negatively, 
showing a similar ratio of Firmicutes/Bacteroidetes compared to a positive control (FOS). LOPP exhibit a positive 
(similar to FOS) effect on the Prevotella spp./Bacteroides spp. ratio. Both powders promoted more the production 
of short-chain fatty acids (mainly acetate > butyrate > propionate) than FOS and showed also significant total 
phenolic content and oxygen radical absorbance capacity during faecal fermentation until 48 h. Besides that, 
these powders showed mucin-adhesion inhibition ability against pathogens, principally POPP against Bacillus 
cereus (22.03 ± 2.45%) and Listeria monocytogenes (20.01 ± 1.93%). This study demonstrates that olive pomace 
powders have prebiotic effects on microbiota, including the stimulation of short-chain fatty acids production, 
potential antioxidant and antimicrobial activity which could improve the human gut health.   
1. Introduction 
Sustainable and functional ingredients have been developed from 
several food by-products. This trend towards a circular economy model 
has been rising as an opportunity to manage the environmental and 
nutritional problems of today’s society, also allowing the generation of 
economic gains for the food industry (Torres-León et al., 2018). Pres-
ently, there is a stimulus to reduce the disposal of olive oil production 
by-products, specifically the olive pomace (OP), which represents the 
major environmental problem and cost of this industry (Conterno et al., 
2019). 
OP has been extensively investigated to obtain new functional and 
bioactive ingredients due to its richness in olive oil phenolics (Nunes 
et al., 2016). Recently, OP dietary fibre (DF) has also been explored 
(Galanakis, 2011; Ying et al., 2017). However, until now, these func-
tional ingredients have been developed involving the use of organic 
solvents or requiring higher operational costs and valorising only a small 
fraction of the OP. So, to fulfil this lack, we have developed a 
liquid-enriched olive pomace powder (LOPP) and pulp-enriched olive 
pomace powder (POPP). These OP powders have been described as 
important sources of DF, olive oil phenolics and soluble sugars (Ribeiro 
et al., 2020). If LOPP is mainly a source of phenolics and sugars, POPP 
contains a significant amount of insoluble dietary fibre (IDF), mainly 
constituted by lignin but also cellulose, hemicellulose and bound phe-
nolics associated with DF. 
The main OP powder phenolics (hydroxytyrosol and derivatives) 
were known to have several health benefits linked to cardiovascular 
disease prevention (Robles-Almazan et al., 2018) (e.g. protectors from 
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oxidative damage of low-density lipoprotein (LDL) particles (EFSA, 
2011)). However, OP phenolics have also been described as antimicro-
bial agents against both Gram-positive/Gram-negative bacteria and 
stimulants of the growth of beneficial bacteria in the gut 
(KarkovićMarković et al., 2019; Mosele et al., 2014). Not only DF and its 
associated bound phenolics, often referred to as non-digestible poly-
saccharides, may remain unaltered until reaching the colon (Arranz 
et al., 2010; Papillo et al., 2014; Sato et al., 2011), but also not all 
polyphenols are absorbed in the small intestine and could reach the 
colon (Mosele et al., 2014). In the gut, DF and phenolics could be 
fermentable and undergo biotransformation by the gut microbiota 
(Lattimer & Haub, 2010; Williams et al., 2017) increasing the beneficial 
bacteria content, the short-chain fatty acids (SCFAs) production and 
exerting other potential health benefits associated to phenolics action 
(Arranz et al., 2010; Papillo et al., 2014; Sato et al., 2011). 
The literature supported the prebiotic potential of OP powders. Ac-
cording to the most recent definition of ‘prebiotic’ proposed by ISAPP 
consensus panel as ‘a substrate that is selectively utilised by host microor-
ganisms conferring a health benefit’, other substances such as polyphenols 
and not only the usual carbohydrate-based compounds, might fit the 
updated definition, assuming adequate evidence of health benefit for the 
target host (Gibson et al., 2017). Phenolic compounds were pointed as 
potential prebiotic candidates, with enhancer benefits on microbiota 
composition, gut permeability and anti-inflammatory/immunity mech-
anisms (Papillo et al., 2014; Williams et al., 2017). However, far more 
studies in the target host are required to validate phenolic ‘prebiotic 
effects’ (Gibson et al., 2017). In conclusion, prebiotics are compounds 
that have the potential to improve human health and reduce the risk of 
diseases mediated by microbiota dysbiosis (Gibson et al., 2017). 
The specific stimulation of the growth and/or activity of intestinal 
bacteria associated with health and well-being was considered a ‘pre-
biotic effect’. In this field, the sequencing techniques, especially 16S 
rRNA-based approaches, have been revolutionising the study of changes 
in human faecal microbial communities (Wang et al., 2019). On the 
other hand, the release of SCFAs (acetate, propionate and butyrate) as a 
result of microbial fermentation of phenolics and DF, if measurable, as 
distinct from a control, could also constitute a ‘prebiotic effect’. These 
SCFAs are metabolised by the colonic epithelium (butyrate), liver 
(propionate) and muscle (acetate), exerting different functions with an 
essential role in health and disease (Laparra & Sanz, 2010). At the same 
time, an increase in the antioxidant phenolic compounds generated as 
microbial metabolites could also be found with the potential to decrease 
the local oxidative stress. So, besides the ‘prebiotic effects’, phenolics 
could also exert potential antioxidant and/or antimicrobial effects 
(against pathogens) on the gut. 
The impact of the gastrointestinal tract on OP powders, regarding the 
recovery and bioaccessibility of bioactive compounds, has been assessed 
(Ribeiro et al., 2020). However, the potential beneficial effect on the gut 
of DF and phenolics (free and bound form) retained in significant 
amounts in the colon fraction has not been disclosed yet. Few studies 
have analysed the potential prebiotic and antioxidant impact on the gut 
microbiota of olive oil (Liehr et al., 2017; Mosele et al., 2014; Santos 
et al., 2012) and olive leaf extracts (Aponte et al., 2018; Haddadin, 
2010), but until now the influence of OP on the composition of human 
gut microbiota was only assessed by Conterno et al. (2019). In this study, 
the 16S rRNA gene analysis allowed to validate that OP incorporated 
into biscuits did not impact negatively on the diversity of the faecal 
microbiota. The effect of the OP oil as a dietary supplement on the 
rumen microbial community profile in Comisana ewes was also inves-
tigated decreasing the population of lipase-producing microorganisms 
(Anaerovibrio spp.), lipolysis rate and the concentration of poly-
unsaturated fatty acids involved in biohydrogenation (Mannelli et al., 
2018). 
According to our knowledge, there are no studies where the OP food 
ingredients prebiotic potential was assessed by in vitro fermentation with 
faecal inocula. Therefore, for the first time, the present study intends to 
analyse the potential prebiotic effect of OP powders and their potential 
antioxidant and antimicrobial effects on gut health. Not only the OP 
powders capacity to modulate the gut microbiota composition and its 
metabolic activity were studied by copy of the 16S rRNA gene of the 
bacterial population and quantifying the amount of SCFAs produced 
after the in vitro colonic fermentation, but also their ability to create an 
antioxidant environment in the gut by liberation of phenolic metabolites 
(LC-ESI-UHR-QqTOF-MS) and to inhibit the adhesion of pathogens 
(antiadhesion ability) were assessed. In short, a complete in vitro screen 
of the OP powders potential as prebiotics and gut-health benefits in-
gredients is aimed in this study. 
2. Materials and methods 
2.1. Preparation of olive pomace powders 
OP was collected from an olive mill from Oliveira do Hospital, 
Portugal, being composed mainly by the olive cultivar Galega Vulgar 
(80% of the olive heritage). Samples from different hours of the day of 
the olive oil production were taken and transported to the laboratory, 
where they were mixed. The homogenous sample obtained from this 
procedure was packed in polyethene flasks and kept in a freezer at - 
80 ◦C until use to minimise polyphenols damage. 
OP was fractionated by centrifugation (10,000 g for 10 min). The 
liquid fraction was freeze-dried (Telstar Lyo Quest HT 40) with 2% of 
mannitol (as a cryoprotectant and to prevent aggregation), and the 
powder obtained was denominated liquid-enriched olive pomace pow-
der (LOPP). The solid fraction was oven-dried (90 ◦C, water activity <
0.4, 90 min), milled using a coffee grinder and sieved (mesh 40). All the 
pieces of stones were removed to obtain a potentially food-grade 
ingredient free of the small stones, which is a potential physical haz-
ard. This fraction was denominated pulp-enriched olive pomace powder 
(POPP). 
2.2. Simulated in vitro gastrointestinal digestion and large intestine 
fermentation model 
POPP and LOPP in vitro simulations of gastrointestinal digestion 
(SGD) were performed according to the method that includes the dial-
ysis process in order to simulate intestinal and blood absorption 
described by (Ribeiro et al., 2020). Mouth digestion was conducted with 
0.6 mL of 100 U/mL α–amylase solution (Sigma) and incubation took 
place for 1 min, at 37 ◦C and 200 rpm. For gastric digestion, the pH was 
adjusted to 2.0 with concentrated HCl (1 mol L− 1), and the mixture was 
incubated with 25 mg/mL of pepsin (from porcine stomach mucosa, 
pepsin A 250 U/mg, Sigma), at a rate of 0.05 mL/mL of sample, in a 
shaking bath, for 60 min at 37 ◦C. Intestinal digestion was performed by 
adjusting pH to 6.0 with NaHCO3 (1 mol L− 1), before the addition of 2 g 
L− 1 of pancreatin (from porcine pancreas 8 x USP, Sigma) and 12 g L− 1 
of bile salts (Sigma), at a ratio of 0.25 mL/mL of sample, and further 
incubation of the mixture for an additional 120 min at 37 ◦C. In the last 
phase of intestinal digestion, a segment (10 cm) of dialysis tubing (3.5 
kDa molecular weight cut-off) filled with NaHCO3 (1 mol L− 1) was 
placed inside of screw-topped bottles filled with digested samples and 
incubated for 2 h in a shaking water bath, at 37 ◦C and 50 rpm. 
At the end of the incubation process, the solution left outside the 
dialysis tubing (OUT) represented the non-absorbable sample (colon- 
available). The OUT sample was homogenised and partitioned in two 
portions. One portion was centrifuged for 12 min at 8000 g at 4 ◦C, 
yielding the soluble fractions and the pellet fractions. Soluble fractions 
were lyophilised and used to evaluate the antiadhesion ability. The other 
OUT portion was lyophilised and then exposed to faecal fermentation 
using fresh faecal inoculum (maintained under anaerobic conditions, for 
a maximum of 2 h before being used) obtained from five healthy donors 
(A-E, two men and three women, ages between 23 and 63 years old) 
according to the methodology developed by Gullon et al. (2015) and 
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Gullón et al. (2014). The faecal inocula (FI) were prepared in an 
anaerobic workstation by diluting (100 g L− 1) the faecal matter in 
Reduced Physiological Salt solution (RPS) (constituted by 0.5 g L− 1 
cysteine-HCl (Merck, Darmstadt, Germany) and 8.5 g L− 1 NaCl (Lab-
Chem, Zelienople, USA) with a final pH value of 6.8 (10% CO2, 5% H2 
and 85% N2). The flasks containing 50 mL of Nutrient Base Medium 
(NBS – Procedure of preparation in Supplementary material A1) were 
capped and autoclaved. Following sterilisation, and before adding the 
faecal inocula, the freeze-dried digested olive pomace powders biomass 
were added to the respective vessels at a final concentration of 20 g.L− 1. 
In other flasks, fructooligosaccharides (FOS) (Nutripar, Matosinhos, 
Portugal) in the same concentration as a positive control were added. 
FOS are well-known prebiotics, which is often used to be positive con-
trols in fermentation experiments in vitro. Flasks without substrate only 
NBS (60 mL) were used as blanks. Then, the atmosphere of each flask 
was refluxed with a gas mixture (10% CO2, 5% H2 and 85% N2) sterilised 
using a 0.22 μm filter (Millipore, Burlington, USA) followed by inocu-
lation at 2% (v/v) with FI and incubated for 48 h at 37 ◦C under 
anaerobic atmosphere (10% CO2, 5% H2 and 85% N2). Samples were 
collected after 0, 12, 24 and 48 h of incubation (4 mL) and the pH values 
were measured using a MicropH 2002 pH meter (Crison, Barcelona, 
Spain), equipped with a 52-07 pH electrode (Crison, Barcelona, Spain). 
The positive control and blank were respectively designated as FOS and 
Blank (only faecal inocula), while the powders obtained from the olive 
pomace digested were dubbed as POPP for pulp-enriched powder and 
LOPP for liquid-enriched powder. Afterwards, the samples were stored 
at − 30 ◦C until analysis. All the steps considered in this section were 
carried out inside an anaerobic workstation (Don Whitley Scientific, 
West Yorkshire, UK). 
Aliquots (4 mL) of each sample collected were centrifuged for 6 min. 
The resulting pellet was used to extract the genomic DNA. On the other 
hand, the supernatants were used to evaluate short-chain fatty acid 
(SCFA) production, the amount of total phenolic acids (TPC), identifi-
cation of phenolic acids and its metabolites and even the potential 
antioxidant activity (AOX). 
2.3. Bacterial population analysis 
2.3.1. DNA extraction and real-time quantitative polymerase chain 
reaction 
DNA was extracted using an NZY Tissue gDNA Isolation kit (NZY-
Tech, Lisbon, Portugal) according to the manufacturers’ instructions, 
with some adaptations (Supplementary Material A2). Afterwards, copy 
numbers of the 16S rRNA gene from the Firmicutes, Lactobacillus spp., 
Enterococcus spp., Clostridium leptum, Bacteroidetes, Bacteroides spp., 
Prevotella spp., and Bifidobacterium spp. groups were determined using 
primers obtained from STABvida (Lisbon, Portugal), according to a real- 
time polymerase chain reaction (RT-PCR) using a CFX96 Touch™ Real- 
Time PCR Detection System (Bio-Rad Laboratories, Inc., Hercules, USA), 
under conditions adapted from Marques et al. (2016) and detailed in 
Supplementary Material A2. 
2.4. Short-chain fatty analysis 
Short-chain and branched-chain fatty analysis were determined in 
supernatants resulted from the faecal fermentation (Gullon et al., 2015). 
The analyses were performed using a Beckman Coulter System Gold 
HPLC (Knauer, Berlin, Germany) coupled to IR and UV detector using 
Aminex 37-H column (Bio-rad, Berkeley, USA) at 55 ◦C and 35 mmol L− 1 
H2SO4 as mobile phase (flow rate: 0.5 mL/min). The identification and 
quantification were achieved by comparison of the relative retention 
times of sample peaks with standards and using a calibration curve in the 
range of concentrations of 0.2–2.0 mg mL− 1. 
2.5. Phenolic compounds analysis 
2.5.1. Total phenolic compounds and antioxidant activity 
The total phenolic content (TPC) of supernatants were determined 
according to the Folin-Ciocalteu method (Oliveira et al., 2016; Singleton 
& Rossi, 1965). Results were expressed as mg gallic acid equivalents 
(GAE)/g of dry weight (DW). 
The antioxidant activity (AOX) of supernatants of each OP powder 
and controls throughout the faecal fermentation was achieved according 
to the methods of ORAC (Costa et al., 2019) using a multidetection plate 
reader (Synergy H1, Vermont, USA). The radical stock solutions were 
freshly prepared. All analyses were performed in triplicate and 
expressed in μmol L− 1 of Trolox-equivalents (TE)/g DW. 
2.5.2. Identification of phenolic compounds by LC-ESI-UHR-QqTOF-MS 
The complete profile of phenolic compounds and its derivatives in 
supernatants of faecal fermentation of three donors were analysed in an 
LC-ESI-UHR-QqTOF-MS following the methodology of Monforte et al. 
(2018). Identification of main olive phenolic compounds was based on 
the retention time, UV–Vis and mass spectra with those obtained from 
the standard solutions, when available. The other peaks were tentatively 
identified comparing the information with available data reported in the 
literature (Ribeiro et al., 2020). Data from Phenol-Explorer 3.6 listed 
under “polyphenol metabolites” (http://phenol-explorer.eu/metabolite 
s) was used as a reference for compound identification. The elemental 
composition for compounds was confirmed according to accurate mass 
(5 mDa), and isotope rate calculations designated mSigma (<20) 
(Bruker Daltonics). 
Phenolic metabolites that passed the mass accuracy and frequency of 
detection thresholds, that had plausible chromatogram peak features, 
and that showed significantly different trends from the control (faeces 
only), were considered as potential polyphenol fermentation markers. 
2.6. Evaluation of the antiadhesion ability in mucin 
The Gram-positive food contaminant/pathogenic bacteria (Bacillus 
cereus ATCC 2599 and Listeria monocytogenes 13562) and Gram-negative 
food contaminant/pathogenic bacteria (Yersinia enterocolitica NCTC 
10406 and Escherichia coli ATCC 25922) were used to study the anti-
adhesion ability of OP powders digested. Suspensions of overnight cul-
tures were adjusted to a final concentration of 108 colony forming units 
(CFU)/mL on a DEN-1 McFarland densitometer (Biosan, Latvia). The 
antiadhesion ability was estimated according to a modified method of 
Valeriano et al. (2014) and Vunduk et al. (2019). Antiadhesion assays 
were performed in flat bottomed 96-well polystyrene microtitre plates 
(Tissue Culture Testplate; SPL Life Sciences, Pocheon, Korea) using pig 
ileal mucin (1 mg mL− 1 and) as a matrix. Approximately 100 μL of mucin 
solution (1 mg mL− 1) in 10 mmol L-1 phosphate-buffered saline (PBS) 
buffer was immobilised on the plate wells for 1 h and subsequently 
incubated overnight at 4 ◦C. Wells were washed twice with 200 μL PBS 
buffer and incubated with 100 μL (20 mg mL− 1) bovine serum albumin 
(BSA) (Sigma) for 2 h at 4 ◦C. Wells were again washed twice with 200 
μL of PBS buffer to remove unbound BSA. Approximately 50 μL of 
bacterial suspension (approx. 108–109 CFU mL− 1) was washed and 
suspended in 10 mmol L− 1 PBS buffer and added to the wells. Addi-
tionally, in control samples, 50 μL of PBS and to OP samples 50 μL of 
each OP powder (2% m/v) were added. Then plates were incubated at 
37 ◦C for 1 h. After incubation, wells were washed five times with 200 μL 
sterile citrate buffer to remove unbound bacteria. Another 200 μL of 
0.5% (v/v) Triton X-100 was then added to isolate attached bacteria. 
The viable cell count expressed as CFU mL− 1 was determined in all cases 
by plating on specific media. Each assay was performed in triplicate with 
each trial having more than two replicates each. The percentage of in-
hibition of bacterial adhesion in the presence of OP powders was 
calculated as: 




Values of log 16S rRNA gene copies/ng of DNA of gut bacterial population sizes after 12, 24 and 48 h of the in vitro faecal fermentation of OP powders.  
Samples Time (h) Gut microbiota 




Total Lactobacillus spp. Enterococcus spp. Clostridium leptum Total Prevotella spp. Bacteroides spp. Bifidobacterium spp. 
Blank 0 7.12 ± 0.41 a 2.06 ± 0.42 a 2.84 ± 0.66 a 5.52 ± 0.16 a 5.64 ± 0.11 b 4.11 ± 0.88 a 2.73 ± 0.61 b 3.96 ± 0.34 a 1.44 ± 0.07 a, A 1.57 ± 0.44 a, A 
12 7.20 ± 0.46 a, A 2.34 ± 0.24 a, A 3.52 ± 0.78 a, A 4.91 ± 0.39 a, A 6.60 ± 0.18 a, A 4.77 ± 0.35 a, A 5.08 ± 0.46 a, A 3.82 ± 0.37 a, B 1.13 ± 0.02 b, A 0.94 ± 0.07 a, A 
24 7.64 ± 0.23 a, AB 1.96 ± 0.39 a, AB 2.84 ± 0.69 a, A 4.89 ± 0.14 a, A 5.42 ± 0.23 b, A 3.82 ± 0.62 a, A 2.63 ± 0.37 b, A 3.72 ± 0.13 a, B 1.44 ± 0.06 a, A 1.48 ± 0.33 a, A 
48 7.56 ± 0.28 a, A 1.54 ± 0.31 a, AB 2.79 ± 0.61 a, A 5.07 ± 0.25 a, A 5.49 ± 0.20 b, A 3.57 ± 0.14 a, A 2.54 ± 0.11 b, AB 3.37 ± 0.13 a, A 1.38 ± 0.03 a, A 1.41 ± 0.05 a, B 
FOS 12 7.46 ± 0.38 a, A 2.41 ± 0.24 a, A 4.39 ± 0.66 a, A 4.94 ± 0.51 a, A 6.68 ± 0.37 a, A 5.22 ± 0.79 a, A 4.71 ± 0.17 a, A 4.87 ± 0.30 a, A 1.12 ± 0.06 b, A 1.10 ± 0.13 b, A 
24 7.12 ± 0.18 ab, A 2.49 ± 0.40 a, A 4.21 ± 0.28 a, A 4.71 ± 0.23 a, AB 4.94 ± 0.49 b, A 3.92 ± 0.67 a, A 2.41 ± 0.39 b, A 4.94 ± 0.50 a, A 1.50 ± 0.13 a, A 1.65 ± 0.29 ab, A 
48 6.44 ± 0.52 b, B 1.91 ± 0.33 a, A 3.16 ± 0.39 a, A 4.31 ± 0.35 a, A 4.52 ± 0.37 b, A 3.49 ± 0.22 a, A 1.86 ± 0.27 b, B 3.92 ± 0.57 a, A 1.40 ± 0.15 ab, A 2.00 ± 0.11 a, A 
POPP 12 7.36 ± 0.44 a, A 1.42 ± 0.23 a, B 3.61 ± 0.77 a, A 4.50 ± 0.25 a, A 6.65 ± 0.97 a, A 4.70 ± 0.17 a, A 4.40 ± 0.29 a, A 3.50 ± 0.41 a, B 1.13 ± 0.20 a, A 1.07 ± 0.10 b, A 
24 7.74 ± 0.31 a, A 1.01 ± 0.18 a, B 3.50 ± 0.61 a, A 4.41 ± 0.38 a, AB 5.70 ± 0.45 a, A 4.31 ± 0.16 a, A 2.83 ± 0.27 b, A 3.39 ± 0.38 a, B 1.36 ± 0.10 a, A 1.60 ± 0.13 a, A 
48 7.70 ± 0.19 a, A 0.83 ± 0.15 a, B 3.39 ± 0.63 a, A 4.50 ± 0.20 a, A 5.65 ± 0.26 a, A 4.13 ± 0.37 a, A 2.89 ± 0.20 b, A 3.15 ± 0.35 a, A 1.36 ± 0.07 a, A 1.43 ± 0.08 a, B 
LOPP 12 7.08 ± 0.85 a, A 0.69 ± 0.08 a, c 2.90 ± 0.70 a, A 4.18 ± 0.43 a, A 7.01 ± 1.01 a, A 4.51 ± 0.18 a, A 4.80 ± 0.27 a, A 3.22 ± 0.24 a, B 1.03 ± 0.22 b, A 0.96 ± 0.06 b, A 
24 7.71 ± 0.47 a, A 0.81 ± 0.20 a, B 3.52 ± 0.60 a, A 4.27 ± 0.21 a, B 4.92 ± 0.86 a, A 3.45 ± 0.25 b, A 2.51 ± 0.09 b, A 3.57 ± 0.30 a, B 1.60 ± 0.23 a, A 1.38 ± 0.16 a, A 
48 7.52 ± 0.62 a, A 1.07 ± 0.19 a, AB 3.40 ± 0.70 a, A 4.46 ± 0.31 a, A 5.01 ± 0.83 a, A 3.81 ± 0.10 b, A 2.33 ± 0.41 b, AB 3.21 ± 0.49 a, A 1.52 ± 0.16 ab, A 1.59 ± 0.33 a, AB 
Results are the means of five determinations ± standard deviation. Different letters indicate significant differences (p < 0.05). The capital letters indicate the differences among Blank, FOS, and OP powders for the 
population of same microbial genus at the same time, and small letters indicate the differences for the same sample among time for the population of the same microbial genus. 
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× 100 (1)  
Where CFUControl was the average for control samples, and CFUSample was 
the average for treated samples. 
2.7. Statistical analyses 
The statistical analyses were carried out using R software. The sig-
nificance of the differences between samples after in vitro colonic 
fermentation was determined by one-way analysis of variance (ANOVA) 
or Kruskal-Wallis according to the normality of data distribution (Sha-
piro-Wilk test) and homogeneity of variances (Levene’s test).Test 
multiple comparisons were made at those statistically significant vari-
ables using the Tukey’s posthoc test or Dunn’s method at the p < 0.05 
significance level. 
Supervised cluster analysis (Partial Least Squares Discriminant 
Analysis (PLS-DA)) and hierarchical clustering analysis (HCA) were 
applied to evaluate the metabolite patterns of OP powders detected 
(relative intensity) as a function of time using MetaboAnalyst 3.0 
(http://www.metaboanalyst.ca/) on log-transformed data after 
autoscaling (mean-centred and divided by the standard deviation of 
each variable). The HCA was applied with Euclidean distance measure 
and Ward clustering algorithm. 
Fig. 1. Concentrations of short-chain fatty acids (SCFAs) produced after 12, 24 and 48 h in vitro faecal fermentation of OP powders.  
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3. Results and discussion 
3.1. Changes in faecal microbial communities during in vitro fermentation 
The real-time PCR investigation on the microbial groups’ Firmicutes, 
Lactobacillus spp., Enterococcus spp., Clostridium leptum, Bacteroidetes, 
Bacteroides spp., Prevotella spp., and Bifidobacterium spp. were used to 
assess the OP powders effect on gut microbiota. For comparison, FOS 
was used as a positive control, i.e. compound with a prebiotic effect on 
the gut microbiota. As seen in Table 1, the most significant effects of OP 
powders were verified in Firmicutes and Bacteroidetes groups (p < 0.05). 
In healthy adults, the Gram-positive Firmicutes and the Gram-negative 
Bacteroidetes are the main phyla in the human gut microbiome (Abe-
navoli et al., 2019). During the time of fermentation, the highest 
amounts of Firmicutes and Bacteroidetes were verified after 12 h of 
fermentation of FOS and OP powders. After 24 and 48 h, OP powders 
showed that they could maintain the growth of these two major phyla 
without decreasing their amounts significantly. On the other hand, FOS 
influenced more positively the amount of Firmicutes and Bacteroidetes 
until 12 h of fermentation, but cell numbers decreased significantly after 
that (p > 0.05). These decreases could be related to the fact that the in 
vitro faecal fermentation of this work was performed without pH control. 
OP powders seemed to have a more prolongated positive effect on Fir-
micutes and Bacteroidetes than FOS. Indeed, POPP increased significantly 
(p < 0.05) the amount of Firmicutes compared to the FOS, principally 
after the 48 h of fermentation. This result was expected due to the higher 
amount of dietary fibre of POPP. Previous studies showed that diets low 
in fat and high in dietary fibre were associated with higher Firmicutes 
amount (Simpson & Campbell, 2015). Regarding Bacteroidetes, OP 
powders and FOS had a positive and similar effect on this group (p <
0.05) after 12, 24 and 48 h of in vitro colon fermentation. 
It is known that more important than the stimulation of the amount 
of Firmicutes and Bacteroidetes, it is to maintain the relative abundance of 
these two prominent phyla (Simpson & Campbell, 2015). Commonly, 
healthy individuals display a nearly 1:1 ratio of Firmicutes to Bacter-
oidetes (F/B) (Cockburn & Koropatkin, 2016) and its increase (e.g., to 
20:1) or decrease have been associated with obesity and weight loss, 
respectively (Koliada et al., 2017). OP powders and FOS maintained the 
ratio of F/B stable and near to one without significant differences. 
Another important ratio is the Prevotella spp. to Bacteroides spp. (P/B) 
ratio. Bacteroides spp. and Prevotella spp. belong to the Bacteroidetes 
phylum and are among the most abundant anaerobes in the human 
colon (Flint & Duncan, 2014). If higher levels of Bacteroides spp. are 
related with a superior intake of fat and protein, increased levels of 
Prevotella spp. are correlated with high carbohydrates and fibre intake 
(Jiao et al., 2019; Kovatcheva-Datchary et al., 2015). An increasing 
number of studies have suggested that Prevotella spp. is a microbial 
group associated with beneficial gut microbiota (Rui et al., 2019), 
particularly in the improvement of glucose metabolism (Kovatch-
eva-Datchary et al., 2015). On the other hand, Bacteroides spp. had 
demonstrated potential health benefits for hosts by suppressing intesti-
nal inflammatory responses and promoting intestinal homeostasis (Rui 
et al., 2019). However, a higher P/B ratio protects against Bacteroides 
spp. -induced glucose intolerance (Kovatcheva-Datchary et al., 2015). 
FOS and OP powders increased P/B ratio through fermentation. LOPP 
and FOS improved P/B ratio until 48 h of fermentation without signif-
icant differences. Instead, POPP had a similar effect to FOS and LOPP 
until 24 h. The amount of Prevotella spp. between OP powders was very 
similar throughout fermentation. The higher amount of Prevotella spp. 
throughout fermentation could be explained by the high amount of di-
etary fibre and soluble sugars (mainly the polyol mannitol, which is 
considered a prebiotic substance) on POPP and LOPP (Supplementary 
material A3), respectively (Jiao et al., 2019; Kovatcheva-Datchary et al., 
2015). On the other hand, the higher amount of Bacteroides spp. after 24 
and 48 h of POPP fermentation could be related to its higher amount of 
fat (Supplementary material A3). 
Regarding the other bacteria of Firmicutes phylum evaluated, OP 
powders did not negatively affect the Lactobacillus spp., Clostridium 
leptum and Enterococcus spp. genus compared to the blank. However, 
FOS exhibited a significant positive effect on the growth of Lactobacillus 
spp. group compared to OP powders (p < 0.05). In the Actinobacteria 
phylum, the same behaviour with FOS and OP powders was verified 
when compared to the Bifidobacterium spp. group, associated with health 
positive effects. 
Regarding the time of fermentation, OP powders were fermented 
more slowly than FOS. Most in vitro fermentation studies suggest that 
less soluble substrates (e.g., insoluble arabinoxylan, cellulose) and with 
longer chain lengths are fermented more slowly. POPP, as reported in 
our previous work, was mainly a source of insoluble cellulose and ara-
binoxylan (Supplementary material A3), which explain its slower 
fermentation rates by microbiota. On the other hand, LOPP is mostly a 
source of mannitol and phenolics, which are metabolised by gut 
microbiota, but less than oligosaccharides such as FOS and inulin. 
Mannitol effect as potential prebiotic was reported upon its use as a 
substrate on the acrylic pathway, which is observed only in some Clos-
tridium spp. and Prevotella spp., such as C. propionicum and P. ruminicola 
(Maekawa et al., 2009). In turn, as shown by Parkar et al. (2013), in 
order to increase the gut microbiota in the same degree than oligosac-
charides, polyphenols needed to be supplied at higher concentrations (at 
least ten times more). Nevertheless, the slow fermentation of OP pow-
ders could be an advantage in terms of health benefits, e.g. to avoid the 
production of gases that can result in discomfort, such as bloating and 
flatulence, and will also allow the production of SCFAs throughout the 
colon preventing colon cancer, which mainly occurs in the distal colon 
(Seong et al., 2019). 
Until now, the influence of OP on the composition of human gut 
microbiota was only assessed by incorporating the OP into a biscuit 
formulation (Conterno et al., 2019). In the Conterno et al. (2019) study, 
the potential of an olive pomace-enriched biscuit formulation delivering 
17.1 ± 4.01 mg/100 g of hydroxytyrosol and its derivatives to modulate 
the composition and metabolic activity of the human gut microbiota was 
measured by a double-blind, controlled parallel dietary intervention 
during 8 weeks. The 16S rRNA metagenomics analysis of dominant 
bacterial phyla revealed a change in relative abundance at the genus 
level for Bifidobacterium spp., Ruminococcus spp. and Lactobacillus spp., 
while quantitative analysis using fluorescent in situ hybridisation 
coupled with flow cytometry did not confirm these Results. Besides, 
qPCR showed a slight increase in Bifidobacterium spp. group. 
As in the study of Conterno et al. (2019), the analysis of the 16S rRNA 
gene results (Table 1) allowed to validate that OP powders did not 
impact negatively on the diversity of the faecal microbiota. 
3.2. Short-chain fatty acids production during in vitro faecal fermentation 
The changes in the concentration of SCFAs after the fermentation of 
OP powders (2%) and FOS (2%) with human faeces in basal media 
analysed by HPLC are presented in Fig. 1. 
Results are the means of five determinations ± standard deviation. 
Different letters indicate significant differences (p < 0.05). The capital 
letters indicate the differences among Blank, FOS, and OP powders for 
short-chain fatty acids concentration at the same time, and small letters 
indicate the differences for the same sample among time for short-chain 
fatty acids concentration. 
SCFAs are volatile fatty acids produced by the gut microbiota in the 
colon as fermentation products from food components that are unab-
sorbed/undigested in the small intestine, such as acetate, propionate, 
butyrate and valerate (Ríos-Covián et al., 2016a). These SCFAs can be 
produced during growth phases (initial vs late), be present in medium 
composition (presence and absence of amino acids) and be produced by 
metabolic cross-feeding (e.g. consumption of lactate or formate to pro-
duce acetate) (Seong et al., 2019). Butyrate and propionate derive 
exclusively from bacterial metabolism, but acetate could also have an 
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endogenous origin (Pouteau et al., 1998; Tabernero & Gómez de Cedrón, 
2017). 
The OP powders and FOS showed to enhance the production of total 
SCFAs substantially without significant differences between each other. 
However, different production profiles of SCFAs were detected for FOS 
and OP powders. In FOS fermentation, the main metabolite produced 
during the whole fermentation was lactate. On the other hand, lactate 
production was nearly null during OP powders faecal fermentation. The 
low stimulation of Lactobacillus spp. and Bifidobacterium spp. group by 
OP powders explained this limited production of lactate (Dominika 
et al., 2011), validated above with 16S rRNA gene analysis. 
The OP powders enhanced the production of the acetate, propionate 
and butyrate principally in a ratio of 3:1:1, as reported in previous works 
(Cummings, 1981; Scott et al., 2013; Topping & Clifton, 2001). The 
SCFA production stimulated by OP powders and FOS increased 
throughout fermentation time. Nevertheless, only the fermentation of 
OP powders showed an increase in the amount of acetate, propionate 
and butyrate that could be considered significantly different from the 
blank sample (p > 0.05). This higher production of SCFAS was reported 
in other in vitro batch fermentation investigations using human faecal 
inocula with slow fermentation rate like OP powders (Wang et al., 
2019). 
Comparing the OP powders, POPP led to a higher rise of propionate 
production than LOPP after 24 h of faecal fermentation. This high 
amount of propionate resulted from the higher abundance of Bacter-
oidetes detected in POPP when compared to LOPP after 24 and 48 h. 
Bacteroidetes, as members of the polysaccharide-degrading consortia, 
contribute to the release of energy from DF, which is the main compo-
nent of POPP and consequent propionate formation (Flint & Duncan, 
2014; Koh et al., 2016). Bacteroidetes are likely to be the main contrib-
utors to propionate production in the colon (Flint & Duncan, 2014). 
Compared to POPP, only the amount of butyrate was significantly 
higher in LOPP than in POPP after 24 and 48 h of fermentation (p <
0.05). The main butyrate-producing groups belong to Firmicutes phylum 
(De Vuyst & Leroy, 2011; Parkar et al., 2013), more specifically Cop-
rococcus comes, C. eutactus, C. catus, E. rectale, E. hallii, F. prausnitzii, 
Anaerostipes spp., Roseburia spp (Koh et al., 2016). These genera were 
not measured in the present work, and no significant differences were 
observed in phylum Firmicutes between LOPP and POPP. However, a 
typical cross-feeding effect could occur among the genus of intestinal 
bacteria enumerated (except C. comes, C. eutectic) using acetate to syn-
thesise butyrate via the butyryl-CoA: acetate CoA-transferase route (De 
Fig. 2. Total phenolic content (TPC), expressed as gallic acid equivalents (GAE), and antioxidant capacity (ORAC radical scavenging), expressed as trolox equivalents 
(TE) after 12, 24 and 48 h of the in vitro faecal fermentation of olive pomace (OP) powders. (a) OP powders TPC (mg GAE/100 g DW fermented sample) during the 
faecal fermentation in comparison to FOS and Blank. (b) OP powders ORAC (μmol L− 1 TE/g DW fermented sample) during the faecal fermentation in comparison to 
FOS and Blank. (c) OP powders TPC (mg GAE/100 g DW sample) in the digested OP powders and during 8, 24 and 48 h of the in vitro faecal fermentation process. (d) 
OP powders ORAC (μmol L− 1 TE/g DW sample) in the digested OP powders and during 8, 24 and 48 h of the in vitro faecal fermentation process. 
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Vuyst & Leroy, 2011; Koh et al., 2016), which could explain the higher 
amount of butyrate in LOPP fermentation. The LOPP rich composition in 
sugar and formic acid (Supplementary material A3) could enhance the 
production of acetate by enteric bacteria fermentation or by acetogenic 
bacteria fermentation via Wood–Ljungdahl pathway, respectively 
(Seong et al., 2019). In an acetate-rich colon ecosystem, previous studies 
reported that butyryl-CoA: acetate CoA transferase activity has been 
more common among butyrate-producing groups (De Vuyst & Leroy, 
2011; Louis et al., 2004, 2007). This makes LOPP acetate a key inter-
mediate for colon butyrate. On the other hand, as reported by Maekawa 
et al. (2009), mannitol present at substantial amount in LOPP (Supple-
mentary material A3), was associated to the stimulation of the 
lactate-utilising butyrate producers and propionate producers. Other 
reason for the higher increase of butyrate in LOPP fermentation could be 
linked to its higher polyphenols content. Caffeic acid and its derivative 
caffeoyl-6′-secologanoside were detected in higher amounts in LOPP 
undigested fraction (Supplementary material A3), and its metabo-
lisation might be responsible for the enhanced production of butyrate in 
the fermentation of these OP powders. In previous studies, at concen-
trations of 10 and 100 mg mL− 1, the caffeic acid standard exhibited the 
highest increase in butyrate production after 24 h of faecal fermentation 
when compared to other phenolics (chlorogenic acid, caffeic acid, rutin 
and quercetin) and inulin (Parkar et al., 2013). 
The common cross-feeding effect among intestinal bacteria of pro-
duction of acetate, propionate or butyrate as the final metabolite using 
the lactate as substrate (Koh et al., 2016; Seong et al., 2019) was not 
evident during FOS fermentation. Indeed, lactate was accumulated 
throughout the fermentation time, and its utilisation was not verified, 
once the other SCFAs concentrations were maintained or decreased after 
24 h. So, the prevention of the accumulation of lactate in order to sta-
bilise the intestinal environment was not verified in FOS fermentation, 
which could result in further acidosis that could be related with certain 
gut disorders or dietary intakes and lead to adverse consequences 
(Kowlgi & Chhabra, 2015). However, the low pH value of the faecal 
fermentation (the in vitro faecal fermentation experiment of this work 
performed without pH control) of FOS could be responsible for the 
accumulation of lactate (Belenguer et al., 2007). 
The SCFAs as metabolites of gut microbiota are distributed 
throughout the body, having diverse functions such as signalling mol-
ecules and/or energy substrates. In the colon, SCFAs could inhibit 
pathogenic microorganisms, increase the absorption of some nutrients 
and seem to play an essential role in the maintenance of the gut barrier 
function (Ríos-Covián et al., 2016b). During its intestinal absorption, 
butyrate may be metabolised (energy source) by colonocytes. At the 
same time, propionate may be transported to the liver where it has a role 
in gluconeogenesis, and acetate enters the systemic circulation and is 
used in lipogenesis (Scott et al., 2013). SCFAs might play a vital role in 
the metabolic pathways of several organs, modulating different pro-
cesses including cell proliferation and differentiation, hormones secre-
tion (e.g., leptin and peptide YY) and activation of 
immune/inflammatory responses (Gullon et al., 2015; Koh et al., 2016). 
Many biological effects seem to be mediated by SCFAs, namely (1) ac-
etate and propionate might affect satiety and intestinal transit; (2) 
butyrate could exert anti-inflammatory effects; (3) propionate could 
lead to satiety and decreased hepatic glucose production; (4) small 
amounts of SCFAs (mostly acetate and possibly propionate) reach the 
circulation and can also directly affect the adipose tissue, brain, and 
liver, inducing overall beneficial metabolic effects and (5) SCFAs can 
also reduce inflammation and tumorigenesis (Koh et al., 2016; 
Ríos-Covián et al., 2016b). The role of SCFAs in the prevention and 
treatment of several diseases such as metabolic syndrome, bowel dis-
orders and cancer has also been reported in several studies (Gullon et al., 
2015). Still, excessive SCFAs concentrations might induce adverse ef-
fects on gastrointestinal and colonic motility and sensitivity in certain 
diseases such as inflammatory bowel disease and gastro-oesophageal 
reflux disease, and the conclusive proof is not available for many of 
the health claims made for SCFAs (Gullon et al., 2015; Ríos-Covián et al., 
2016b). 
Despite the higher total SCFAs production by FOS, OP powders 
exhibited a profile of SCFAs with a higher concentration of acetate, 
propionate and butyrate throughout the fermentation time. These SCFAs 
could exert interesting, beneficial health properties not only in the colon 
and gut microbiota but also in other organs. So, OP powders could be 
considered prebiotics as inducers of the SCFAs production activity by 
gut microorganisms. 
3.3. Phenolic compounds throughout in vitro faecal fermentation 
3.3.1. Total phenolic compounds and antioxidant activity 
The total phenolic content (TPC), as assayed according to the Folin- 
Ciocalteu method, along with in vitro antioxidant capacity (ORAC 
radical scavenging), was investigated to support the following evalua-
tion of phenolic profile through LC-ESI-UHR-QqTOF-MS. Fig. 2 displays 
the TPC and the in vitro antioxidant capacity (ORAC radical scavenging) 
during in vitro faecal fermentation process (8, 24, and 48 h) in com-
parison to FOS and blank, but also the TPC and ORAC of the digested OP 
powder previously evaluated and throughout the in vitro faecal 
fermentation process (8, 24, and 48 h) expressed by DW of OP powder. 
Comparing TPC Results of OP powders with FOS, OP powders showed 
significant higher TPC values (p < 0.05) due to their richness in poly-
phenolic compounds. Indeed, TPC values were constant during FOS 
faecal fermentation time (3–5 mg GAE/g DW), which corroborates that 
FOS as polysaccharide did not contain polyphenols to liberate after 
microbial fermentation. 
In vitro faecal fermentation Results are the means of five de-
terminations ± standard deviation. *Samples analysed in previous 
works. Different letters indicate significant differences (p < 0.05). The 
capital letters indicate the differences among Blank, FOS, and OP 
powders at the same time, and small letters indicate the differences for 
the same sample among the digestion phase. 
Concerning OP powders, LOPP and POPP revealed similar TPC 
values after 12 and 24 h of faecal fermentation. Indeed, both fermented 
OP powders exhibited the highest TPC after 24 h of in vitro colonic 
fermentation (POPP: 8.92 ± 1.12 mg GAE/g DW; LOPP: 9.78 ± 1.89 mg 
GAE/g DW). Nevertheless, after 48 h of fermentation both OP powders 
decreased their TPC values, even though LOPP kept a significantly 
higher TPC value than POPP (p < 0.05), with values of 5.63 ± 0.82 mg 
GAE/g DW and 4.03 ± 0.35 mg GAE/g DW, respectively. The highest 
TPC values of LOPP throughout in vitro colon fermentation might be 
linked to its higher polyphenol richness (Supplementary material A3). 
As LOPP comprise more polyphenols than POPP, it could originate 
higher amounts of phenolic metabolites during the faecal fermentation 
process as reviewed by Duda-Chodak et al. (2015). A similar increase in 
TPC after 24 h of fermentation was reported for a goji berries mix 
(Rocchetti et al., 2018) and black mulberry (Bao et al., 2019). However, 
Bao et al. (2019) also described that TPC of black mulberry decreased 
from 24 to 48 h of fermentation time as shown to happen for LOPP, 
while TPC of white mulberry decreased until 48 h of fermentation time, 
as observed for POPP. 
Considering the TPC results of the previous works regarding the 
digested OP powders, a significant increase of phenolic compounds 
occurred after faecal fermentation for both OP powders (Fig. 2 c). An 
increase in TPC value from 93% to 255% was exhibited from digested to 
fermented OP powders. Similar levels of increase were reported for 
black mulberry (Bao et al., 2019) after 12, 24 and 48 h. This effect has 
been associated with gut microbiota being capable of transforming 
larger phenolic molecules to smaller ones during colonic fermentation 
(Rocchetti et al., 2018) using the free and bound phenolic fraction of OP 
powders (Rocchetti et al., 2019). The higher amount of bound phenolics 
of POPP could explain the significant increase of TPC just after 12 h of 
fermentation (p < 0.05) when compared to digested POPP. In the case of 
LOPP, only after 24 h of fermentation, the TPC value was significantly 
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Table 2 















In vitro faecal fermentation time (h) 
POPP LOPP 
12 24 48 12 24 48 




D D D D D D 
M2 Hydroxytyrosol glucosideb C14H20O8 7.1 315.1088 315.1085 0.0 9.1 315.1092; 
153.0556; 
123.0451 
D D D D D D 
M3 Hydrated product of the 
dialdehydic form of 
decarboxymethyl-elenolic acidb 




D D D D D D 
M4 3,4 - Dihydroxybenzoic acid c C7H6O4 7.3 153.0193 153.0198 0.3 9.2 153.0198; 
109.0295 
D D ND D D D 
M5 Vanillyl alcohol c C8H10O3 7.4 153.0557 153.0493 0.2 5.2 153.0557; 
123.0447 
ND ND D ND ND ND 
M6 Hydroxytyrosol a C8H10O3 7.5 153.0556 153.0557 0.1 5.7 153.0452; 
123.0457 
D D D D D D 
M7 Oleoside derivative isomerb C17H28O11 7.7 407.1557 407.1559 − 0.5 11.7 151.0760; 
119.0346 
D D D D D D 
M8 Decarboxylated form of 
hydroxy-elenolic acid b 




D D D D D D 
M9 3-(3,4-Dihydroxyphenyl)- 
propionic acid d 
C9H10O4 8.0 181.0506 181.0452 0.0 5.4 181.0507; 
163.0397; 
135.0447 
D D ND D D D 
M10 Tyrosol glucosidec C14H20O7 8.1 299.1139 299.1136 − 0.3 3.2 119.0505; 
137.0244; 
135.0299 
D D D D D D 
M11 Hydroxylated product of the 
dialdehydic form of 
decarboxymethyl-elenolic acid b 
C9H12O5 8.2 199.0612 199.0564 0.0 9.5 199.0616; 
155.0709; 
111.0812 
D D D D D D 




D D D D D D 
M13 p-Coumaroyl-D-glucosec C15H18O8 8.7 325.0925 325.0929 0.4 0.9 326.0976; 
163.0402; 
119.0501 
D D D D D D 
M14 Oleuropein aglycone derivative 
c 
C16H26O10 9.6 377.1453 377.1353 0.3 9.4 377.1452; 
197.0825; 
153.0918 
D D D D D D 
M15 Tyrosol a C8H10O2 9.8 137.0608 137.0608 0.5 4.5 111.0084; 
95.0510 
D D D D D D 
M16 Aldehydic form of 
decarboxymethyl elenolic acid b 
C10H16O5 10.8 215.0925 215.0873 0.1 7.6 215.0925; 
153.0918; 
171.1026 
D D D D D D 





D D D D D D 
M18 3 - (4-Hydroxyphenyl) propionic 
acid d 




D D D D D D 
M19 3-Hydroxyphenilpropionic acid 
d 




D D D D D D 
M20 3 - hydroxy-4- 
methoxyphenyllactic acid d 
C10H12O5 13.0 211.0612 211.0560 0.5 4.0 211.0612; 
165.0569; 
123.0812 
D D D D D D 





D D D ND D D 
M22 Homovanillic acid d C9H10O4 13.7 181.0506 181.0464 0.8 8.7 181.0486; 
137.0611; 
D D D D D D 
(continued on next page) 
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different from the digested LOPP. 
The antioxidant capacity (AOX) of the fermented OP powders was 
determined using the ORAC assay. This method is extensively used to 
assess the chain-breaking antioxidant capacity at physiological pH 
values (Burgos-Edwards et al., 2018). As shown in Fig. 2 b, OP powders 
exhibited higher AOX than FOS and LOPP revealed the highest AOX (p 
< 0.05), following the trend of the TPC values reported. LOPP showed 
similar AOX between 12 and 24 h of faecal fermentation, decreasing its 
AOX value significantly after 48 h (p < 0.05). Previous studies exhibited 
similar behaviour on the evolution of ORAC. Burgos-Edwards et al. 















In vitro faecal fermentation time (h) 
POPP LOPP 
12 24 48 12 24 48 
124.0187; 
109.0656 
M23 Luteolin a C15H10O6 15.9 285.0406 285.0405 0.1 0.8 285.0414; 
151.0037 
D D D D D D  
a Hydroxytyrosol, tyrosol, oleuropein, rutin, luteolin-7-O-glucoside, luteolin, quercetin, apigenin, vanillin, caffeic acid, p-coumaric acid and ferulic acid were identified by 
comparison with the standards. LC-ESI-UHR-QqTOF-MS tentatively identified the other compounds based on accurate mass, isotope rate calculations designated mSigma and 
literature. 
b Lozano-Sánchez et al. (2013). 
c Jerman Klen & Mozetič Vodopivec(2012). 
d Phenol-Explorer 3.6. D – Compound detected; ND – Compound not detected. 
Fig. 3. Chemometrics and cluster analysis of the phenolics and its metabolites identified in olive pomace (OP) powders after 12, 24 and 48h of the in vitro 
faecal fermentation. (a) Partial Least Squares - Discriminant Analysis (PLS-DA) of OP powders faecal metabolite profiles. The relative intensity of the 
metabolites detected in the faecal samples collected by LC-ESI-UHR-QqTOF-MS was used for a supervised clustering analysis by a partial least squares 
discriminant analysis. (b) VIP (Variable Importance in Projection) of phenolic compounds identified following the PLS-DA model, during faecal 
fermentation of OP powders. VIP allowed to measure the variable’s importance in the PLS-DA model. Green and red tiles, respectively, indicate a lower or higher 
intensity of metabolite concentration in the mean of all fermented samples. (c) Hierarchical clustering analysis heatmap of phenolic metabolites identified 
during faecal fermentation of OP powders. Blue and red tiles, respectively, indicate a lower or higher intensity of metabolite concentration in the mean of all 
fermented samples. (For interpretation of the references to colour in this figure legend, the reader is referred to the Web version of this article.) 
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(2018) and Rocchetti et al. (2019) also reported similar ORAC values 
after 8 and 24 h of faecal fermentation of a polyphenolic-enriched 
extract of Ribes punctatum currant and pigmented gluten-free flours of 
red quinoa and black chickpea, respectively. On the other hand, POPP 
revealed a continuous decline of AOX through in vitro colon fermenta-
tion. Burgos-Edwards et al. (2018) and Rocchetti et al. (2019) also re-
ported a similar decrease in ORAC values throughout in vitro colon 
fermentation of a polyphenolic-enriched extract of Ribes magellanicum 
currant and pigmented gluten-free flours of teff and amaranth, respec-
tively. Therefore, LOPP revealed to be a more effective source of anti-
oxidant compounds than POPP in the colon. 
By comparing the ORAC values obtained in previous works for 
digested OP powders and those obtained for fermented OP powders, it 
could be assumed that significant losses of AOX occur during faecal 
fermentation. Similar results were verified in previous investigations 
(Burgos-Edwards et al., 2018; Rocchetti et al., 2019). However, other 
matrices where ORAC values (Burgos-Edwards et al., 2018; Rocchetti 
et al., 2019) were evaluated after 6 and 8 h of fermentation exhibited 
increased ORAC values for a polyphenolic-enriched extract of Chilean 
currants (Ribes punctatum and Ribes magellanicum). For that reason, the 
TPC and ORAC assessment in more fermentation time points might be 
crucial for a superior understanding of the phenolics evolution in a food 
matrix and its metabolites in the colon. The different trend of ORAC and 
TPC values observed between digested and fermented OP powders could 
be explained by the occurrence of different reaction mechanisms of the 
various antioxidants present in the samples, and has been reported in 
previous works (Tabart et al., 2010). 
In conclusion, OP powders provided a potentially higher prebiotic 
effect than FOS in terms of health benefits linked to the creation of an 
antioxidant environment in the gut. OP powders showed to be a valuable 
source of phenolics with antioxidant activity through in vitro colon 
fermentation. Future studies in cell lines and human clinical experi-
ments will be required in order to measure the antioxidant effects 
accurately. 
3.3.2. Identification of phenolic compounds and its metabolites by LC-ESI- 
UHR-QqTOF-MS 
This study was performed to identify the main molecules generated 
by the effect of human microbiota acting on different classes of pheno-
lics present in OP powders. The phenolic profile pattern of the analysed 
fermented OP powders agrees with previous works with OP (Conterno 
et al., 2019) and olive oil (López de las Hazas et al., 2017; Mosele et al., 
2014). 
Identification of phenolic precursors and metabolites derived from in 
vitro microbial colonic fermentation of the OP powders based on high- 
performance LC-ESI-UHR-QqTOF-MS analyses and a summary of mass 
spectrometric specific molecular patterns in negative ionisation are 
summarised in Table 2. Each reported metabolite was detected in at least 
three of the five different donors after 12, 24 or 48 h of faecal 
fermentation. 
PLS-DA of the phenolic metabolite patterns measured in the samples 
derived from OP powders fermentation revealed separate clusters for 
each time of fermentation and sample (Fig. 3 (a)). The scores plot in-
dicates that the first two principal components account for 61.9% of the 
total variance (PC1 = 47.1% and PC2 = 14.8%). If on the one hand the 
three clusters of fermentation time of LOPP were positioned close to 
each other in the III quadrant, on the other hand, the 12 h fermentation- 
cluster of POPP was located on the I quadrant, and the other clusters of 
POPP fermentation (24 and 48 h) were very close to each other in the 
opposite quadrant (II). Therefore, POPP and LOPP exhibited significant 
differences in phenolics throughout faecal fermentation, being sepa-
rated by the most critical factor (PC1), which contributes with 47.1% of 
the total variance. Nevertheless, after 48 h of fermentation, LOPP 
exhibited a phenolic pattern more similar to that of POPP after 24 and 
48 h of fermentation (LOPP - 48 h cluster closer to POPP – 24 and 48 h 
clusters). 
Variable importance in projection (VIP) was obtained (Fig. 3 (b)) in 
order to understand better the differences observed between the 
different clusters of phenolics from OP powders. Markers assigned a VIP 
score >0.8 were counted as the 15 most significative compounds which 
define the phenolics patterns of the OP powders trough faecal fermen-
tation. LOPP, as expected, exhibited a higher relative concentration of 
almost all the phenolic compounds. Hydroxytyrosol glucoside 
(C14H20O8 mz 315.1035), hydroxylated product of the dialdehydic form 
of decarboxymethyl-elenolic acid (C9H12O5 mz 199.0564), a decar-
boxylated form of hydroxyl-elenolic acid (C10H14O5 mz 213.0718) and 3 
- (3,4 - dihydroxyphenyl)-propionic acid (C9H10O4 mz 181.0452) were 
the most significant and at higher relative amounts until 12 h of LOPP 
and POPP fermentation (VIP >1.3). These phenolics decreased 
throughout in vitro fermentation in both OP powders. On the other hand, 
oleuropein aglycone derivative (C16H26O10 mz 377.1353), 3-(4- 
hydroxyphenyl) propionic acid (C9H10O3 mz 165.0505) and oxidised 
hydroxytyrosol (C8H8O3 mz 151.0352) increased after 24 h of LOPP 
fermentation (VIP >1.2). However, in POPP after 24 h of fermentation, 
only oxidised hydroxytyrosol increased, while the oleuropein aglycone 
derivative and 3-(2-hydroxyphenyl) propionic acid decreased. Other 
phenolic acids metabolites identified in LOPP after 24 h of fermentation 
at higher relative concentration were 3-hydroxy-4-methoxyphenyllactic 
acid (C10H12O5 mz 211.0560) (VIP > 1.1) and 3 - (3-hydrox-
yphenilpropionic acid) (C9H10O3 mz 165.0489) (VIP > 0.95). The 3-(3- 
hydroxyphenilpropionic acid) also increased in POPP fermentation until 
48 h of fermentation, and even at a higher rate than in fermented LOPP. 
Vanillyl alcohol (C8H10O3 mz 153.0493) was other metabolite identified 
(VIP > 0.97) at higher concentration in fermented POPP after 48 h. 
Other phenolic acids’ metabolites were also identified in POPP and 
LOPP with low VIP (between 0.3 and 0.1), namely homovanillic alcohol 
(C9H12O3 mz 167.0655) and homovanillic acid (C9H10O4 mz 181.0464). 
All these phenolic acids were reported in previous works with OP bis-
cuits (Conterno et al., 2019) and olive oil (López de las Hazas et al., 
2017; Mosele et al., 2014) as colonic metabolites of olive phenolics and 
precursors of the phenylacetic and phenylpropionic acids. Phenylacetic 
and phenylpropionic acids have been reported as products from the gut 
microbial metabolisation of polyphenols with more strong potential 
health effects, such as anti-inflammatory and antioxidant effects (López 
de las Hazas et al., 2016), as well as acting as prebiotics inhibiting 
pathogenic bacteria and stimulating the beneficial bacteria on the colon 
(KarkovićMarković et al., 2019). 
Hierarchical clustering (HCA) of the relative intensity of the 23 
phenolic metabolites analysed following the faecal fermentation of OP 
powders is presented in Fig. 3 (c). The heatmap shows the clustering of 
phenolic metabolites according to their detection in faecal fermentation 
samples of OP powders. The clustering of the different phenolic me-
tabolites could be divided into two main principal clusters. These clus-
ters allowed to understand the possible colonic transformations of OP 
dietary polyphenols into phenolic acids. For example, oleuropein agly-
cone (M14), hydroxytyrosol (M6), 3-(3,4-dihydroxyphenyl)propionic 
acid (M9), 3,4-dihydroxybenzoic acid (M4) and 3-(4′-hydroxyphenyl) 
propionic acid (M18) were detected in the same principal cluster. 
The formation of aglycones by gut microbiota has been reported 
before as affecting positively or negatively, their activities and func-
tional effects (Laparra & Sanz, 2010). In this work, oleuropein aglycon 
showed to be a key compound in the colonic phenolic pathway of OP 
powders. Most of the identified phenolic metabolites could be obtained 
by the proposed colonic pathway of oleuropein (Mosele et al., 2014). 
The oleuropein aglycone (M14) through hydrolysis could generate 3-(3′, 
4′-dihydroxyphenyl)propionic acid (M9) and hydroxytyrosol (M6), and 
then 3-(3′,4′-dihydroxyphenyl) propionic acid (M9) could be trans-
formed into 3,4-dihydroxybenzoic acid (M4) or 3-(4′-hydroxyphenyl) 
propionic acid (M18) by β oxidation and dihydroxylation, respectively. 
Instead, the colonic pathway of hydroxytyrosol proposed by Mosele 
et al. (2014) could also enlighten the detection of the 4-dihydroxyben-
zoic acid metabolite, which could be found after two successive 
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oxidations reactions: hydroxytyrosol (hydroxytyrosol (M6) oxidation 
into 2-(3′,4′-dihydroxyphenyl)acetic acid which produce 3,4-dihydroxy-
benzoic acid (M4) by α-oxidation. The higher relative concentration and 
VIP of 3-(4′-hydroxyphenyl)propionic acid (M18) compared to 3,4-dihy-
droxybenzoic acid (M4) allowed to hypothesise that the dihydroxylation 
of 3-(4′-hydroxyphenyl)propionic acid (M18) into 3-(3′,4′-dihydrox-
yphenyl) propionic acid (M9) was privileged during colonic fermenta-
tion of OP powders. 
In the other principal cluster, homovanillic acid (M22), homovanillic 
alcohol (M21), vanillyl alcohol (M5) and 3-hydroxyphenilpropionic acid 
(M19) metabolites were detected in growing relative concentrations 
throughout in vitro faecal fermentation, mostly in fermented POPP. 
These compounds could result from the metabolisation of hydroxytyr-
osol. In previous works, hydroxytyrosol was converted to homovanillic 
alcohol (M21) in Caco-2 cells, and homovanillic acid (M22) and 
homovanillic alcohol (M21) were detected in urine after metabolisation 
of hydroxytyrosol supplied by olive oil consumption (Naczk & Shahidi, 
2003). Homovanillic acid (M22) increase was also reported in previous 
work, after ingestion of OP biscuits (in plasma) (Conterno et al., 2019). 
On the other hand, the vanillyl alcohol (M5) and 3-hydroxyphenilpro-
pionic acid (M19) could result from biotransformation of vanillin and 
caffeic acid, respectively. 
The metabolites compounds identified in LOPP and POPP derived 
mainly from the breakdown pathways of the oleuropein aglycon and 
hydroxytyrosol present in significant amount in these OP powders, 
principally in LOPP. Therefore, LOPP exhibited a higher relative con-
centration of phenolic acids metabolites than POPP, in agreement with 
TPC and ORAC Results. Other metabolic pathways could also take place 
during POPP colonic fermentation, taking in consideration the metab-
olites identified in these samples. All steps of the potential metabolic 
pathways identified during in vitro fermentation of OP powders inter-
mediated by the gut microbiota and its catabolites and similar small 
phenolic acids have been reported to be excreted following ingestion of 
olive or olive fractions in previous studies (Conterno et al., 2019). 
3.4. Antiadhesion ability in mucin 
The antiadhesion ability of OP powders (2% m/v) relative to food 
contaminant/pathogenic bacteria is reported in Table 3. However, it is 
essential to clarify that the inhibition of bacterial adhesion can be the 
result of various mechanisms such as cell surface modification, quorum 
sensing, or changes in the cell structure that are not directly connected 
with the antibacterial activity of the tested substance (Vunduk et al., 
2019). 
The Results are expressed as % of adhesion prevention in comparison 
with the control sample (bacteria adhered without the presence of tested 
samples). Results are the means of three determinations ± standard 
deviation. 
Our study showed that OP powders exhibited antiadhesion activity 
towards almost all bacteria, varying between 1.4 and 22%. The most 
pronounced effect was detected for POPP against Gram-positive bacte-
ria. Bacillus cereus (22.03 ± 2.45%) and Listeria monocytogenes (20.01 ±
1.93) adhesions were inhibited at least at 20%. POPP is mostly 
composed by insoluble fibre, but it also contains a considerable amount 
of free and bound phenolic compounds, which may act as anti-adhesion 
agents (Supplementary material A3). Luteolin, for example, it was 
retained in higher amounts in POPP undigested fraction and has been 
described to possess antimicrobial activity against several bacterial 
species (Aziz et al., 2018; Sousa et al., 2006). 
LOPP displayed a weaker antiadhesion activity against Gram- 
positive bacteria (2.86–4.54%) than POPP but demonstrated a higher 
capacity to inhibit the adhesion of Gram-negative bacteria. LOPP 
exhibited a low capacity to inhibit the adhesion of Escherichia coli (1.43 
± 0.27%) and the double of the capacity of POPP from inhibiting the 
adhesion of Yersinia enterocolitica (5.98 ± 1.03%). Its phenolic profile 
could explain the lower antiadhesion activity of LOPP despite its higher 
phenolics content. When comparing LOPP and POPP phenolic profile, it 
can be concluded that LOPP retained higher amounts of tyrosol and 
tyrosol glucoside in the colon after digestion (Supplementary material 
A3). However, tyrosol was reported as the least antimicrobial active 
phenolic molecule from secoiridoid breakdown in Olea europaea 
(Thielmann et al., 2017). On the other hand, the low but higher capacity 
of LOPP to inhibit Gram-negative bacteria could result from synergistic 
effects of polyphenolic compounds and other non-phenolic compounds 
such as minerals (Costa et al., 2019) and organic acids (Östling & 
Lindgren, 1993) (Supplementary material A3). 
In the present study, only one concentration was tested (2% m/v) to 
evaluate the antiadhesion capacity and potential prebiotic effect of OP 
powders simultaneously. However, other concentrations could be tested 
to clarify a possible dose-dependent inhibition activity. 
4. Conclusion 
Prebiotics are defined as substances that induce the growth or 
metabolic activity of microorganisms that contribute to the well-being of 
their host. In this sense, olive pomace powders showed to confer health 
benefits to the gastrointestinal tract as promoters of the production of 
short-chain fatty acids by gut microbiota in a higher degree than fruc-
tooligosaccharides, thus contributing to the improvement of several 
health effects. Equally, olive pomace powders were shown to be a sig-
nificant source of phenolics metabolites after LC-ESI-UHR-QqTOF-MS 
detection. Supervised cluster and hierarchical clustering analysis 
allowed to evaluate the metabolite patterns of olive pomace powders 
phenolics throughout in vitro faecal fermentation, explaining the po-
tential antioxidant activity and antiadhesion ability against food path-
ogens discovered to these powders. Other potential gut health benefits 
could also be expected to olive pomace powders. 
The development of new prebiotics and/or gut-health-benefits 
powders from olive pomace could be an opportunity of adding value 
to the higher by-product stream from the modern olive oil production. 
However, before the development of added value secondary product 
lines, future studies using pH control, cell lines or even clinical studies 
are needed to clarify the potential prebiotic health benefits of olive 
pomace powders. 
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Tânia I. B. Ribeiro thanks the FCT - Fundação para a Ciência e Tec-
nologia, Portugal and Association BLC3 – Technology and Innovation 
Campus, Centre Bio R&D Unit for the PhD Grant SFRH/BDE/108271/ 
2015. This work was supported by National Funds from FCT - Fundação 
para a Ciência e a Tecnologia, Portugal through the project MULTI-
BIOREFINERY - SAICTPAC/0040/2015 (POCI-01-0145-FEDER- 
016403). We would also like to thank the scientific collaboration under 
the FCT project UID/Multi/50016/2019. 
Appendix A. Supplementary data 
Supplementary data related to this article can be found at https:// 
doi.org/10.1016/j.foodhyd.2020.106312. 
References 
Abenavoli, L., Scarpellini, E., Colica, C., Boccuto, L., Salehi, B., Sharifi-Rad, J., Aiello, V., 
Romano, B., De Lorenzo, A., Izzo, A. A., & Capasso, R. (2019). Gut microbiota and 
obesity: A role for probiotics. Nutrients, 11(11), 2690. https://doi.org/10.3390/ 
nu11112690. 
Aponte, M., Ungaro, F., d’Angelo, I., De Caro, C., Russo, R., Blaiotta, G., Dal Piaz, F., 
Calignano, A., & Miro, A. (2018). Improving in vivo conversion of oleuropein into 
hydroxytyrosol by oral granules containing probiotic Lactobacillus plantarum 299v 
and an Olea europaea standardized extract. International Journal of Pharmaceutics, 
543(1–2), 73–82. https://doi.org/10.1016/j.ijpharm.2018.03.013. 
Arranz, S., Silván, J. M., & Saura-Calixto, F. (2010). Nonextractable polyphenols, usually 
ignored, are the major part of dietary polyphenols: A study on the Spanish diet. 
Molecular Nutrition & Food Research, 54(11), 1646–1658. https://doi.org/10.1002/ 
mnfr.200900580. 
Aziz, N., Kim, M.-Y., & Cho, J. Y. (2018). Anti-inflammatory effects of luteolin: A review 
of in vitro, in vivo, and in silico studies. Journal of Ethnopharmacology, 225, 342–358. 
https://doi.org/10.1016/j.jep.2018.05.019. 
Bao, T., Li, Y., Xie, J., Jia, Z., & Chen, W. (2019). Systematic evaluation of polyphenols 
composition and antioxidant activity of mulberry cultivars subjected to 
gastrointestinal digestion and gut microbiota fermentation. Journal of Functional 
Foods, 58(866), 338–349. https://doi.org/10.1016/j.jff.2019.05.017. 
Belenguer, A., Duncan, S. H., Holtrop, G., Anderson, S. E., Lobley, G. E., & Flint, H. J. 
(2007). Impact of pH on lactate formation and utilization by human fecal microbial 
communities. Applied and Environmental Microbiology, 73(20), 6526–6533. https:// 
doi.org/10.1128/AEM.00508-07. 
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